Bausch+Lomb IPO Presentation Deck
April 2022, 63 slides
  1. Bausch+Lomb
  2. Related Decks
  3. IPO Presentation Decks
see better live better investor presentation | Bausch+Lomb
| Bausch+Lomb
offering summary | Bausch+Lomb
today presenters | Bausch+Lomb
our company | Bausch+Lomb
key investment highlights i | Bausch+Lomb
our mission helping you see better to live better | Bausch+Lomb
ame highest brand awareness among peers | Bausch+Lomb
at a glance uta | Bausch+Lomb
legacy of first in class market leading innovation if me | Bausch+Lomb
of the world population has access to products | Bausch+Lomb
large and growing market | Bausch+Lomb
driving significant unmet need in eye health a | Bausch+Lomb
integrated platform uniquely positions to serve eye care needs | Bausch+Lomb
and creates a distinct advantage among eye care competitors | Bausch+Lomb
comprehensive portfolio to treat the entire eye through all phases of life | Bausch+Lomb
global leader with iconic portfolio of brands pita boston | Bausch+Lomb
leading position in vision care market | Bausch+Lomb
top franchises drive revenue growth nice nese | Bausch+Lomb
infuse ultra addressing unmet market need pact ocular surface i i to | Bausch+Lomb
contact lens share has grown by since | Bausch+Lomb
global contact lens market based on reported revenue | Bausch+Lomb
multiple contact lens pipeline products focused on fast growing categories | Bausch+Lomb
key consumer eye care products address customer needs | Bausch+Lomb
brand in redness reliever category | Bausch+Lomb
brand share of category doctor recommended brand over in retail sales years of double digit growth tripled households users since | Bausch+Lomb
continue to build franchises with high brand equity pus | Bausch+Lomb
has an extensive product suite for all major eye health procedures flirt | Bausch+Lomb
invest in technologies to transform our business | Bausch+Lomb
broad portfolio in large ophthalmic pharmaceuticals market a a | Bausch+Lomb
only integrated eye care company with global presence and distinctive capabilities in ophthalmic pharmaceuticals pharmaceuticals i | Bausch+Lomb
significant opportunity for growth indication pipeline product differentiation | Bausch+Lomb
| Bausch+Lomb
an integrated approach to innovation dedicated | Bausch+Lomb
growth momentum today with potential to accelerate with pipeline of innovation | Bausch+Lomb
solving complex eye health problems with integrated approach | Bausch+Lomb
key focus areas to accelerate growth in large market invest in categories growing | Bausch+Lomb
financial performance | Bausch+Lomb
strong fundamentals supporting durable growth | Bausch+Lomb
robust and cash generation with opportunity for expansion | Bausch+Lomb
invested in all areas of since | Bausch+Lomb
opportunity to gain share in large growing markets | Bausch+Lomb
multiple levers for potential margin expansion to a | Bausch+Lomb
financial flexibility and availability of liquidity strong balance sheet liquidity | Bausch+Lomb
preliminary earnings | Bausch+Lomb
transaction summary | Bausch+Lomb
an independent to elevate the power of our integrated care and significant be care innovation to serve unlocks full power of yields flexible balance | Bausch+Lomb
key investment highlights i | Bausch+Lomb
appendix | Bausch+Lomb
leader in eye health for years a | Bausch+Lomb
building an integrated eye health ecosystem | Bausch+Lomb
building a solid track record in quality compliance and efficient production a | Bausch+Lomb
executive officers and management team see | Bausch+Lomb
global brand platform if | Bausch+Lomb
leading eye drop in | Bausch+Lomb
key drivers of value creation leverage the strength of our platform innovative pipeline | Bausch+Lomb
community engagement has yielded significant brand equity | Bausch+Lomb
significant manufacturing capacity to support future growth | Bausch+Lomb
| Bausch+Lomb
reconciliation of reported net loss income to non and adjusted non | Bausch+Lomb
| Bausch+Lomb
non appendix | Bausch+Lomb
non appendix | Bausch+Lomb
See More
Bausch+Lomb
IPO Presentation Decks
Medical Instruments & Supplies Decks
Healthcare Decks
Explore Topics
Surgical
Pharmaceutical
Recent decks by Bausch+Lomb
Results
February 2024
Results
October 2023
Results
August 2023
Results
May 2023
See all presentations by Bausch+Lomb (10 decks)
Related decks
Doximity
Investor Presentation
November 2023
Minerva
IPO
October 2021
Doximity
IPO
May 2023
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
NeuroBo Pharmaceuticals
Securities Offering
October 2022
Orthofix
SPAC
October 2022
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
Comera
Investor Presentation
December 2023
Recent decks by Bausch+Lomb
See all presentations (10 decks)
Results
February 2024
Results
October 2023
Results
August 2023
Results
May 2023
Doximity
Investor Presentation
November 2023
Minerva
IPO
October 2021
Doximity
IPO
May 2023
NeuroBo Pharmaceuticals
Investor Presentation
January 2024
NeuroBo Pharmaceuticals
Securities Offering
October 2022
Orthofix
SPAC
October 2022
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
Comera
Investor Presentation
December 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights